Non-invasive Parenteral Screening Instruments market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-invasive Parenteral Screening Instruments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Ultrasound Devices Next-Generation Sequencing Systems Polymerase Chain Reaction Instruments Microarrays Others Segment by Application Diagnostic Laboratories Hospitals By Company GE Healthcare Philips Illumina Thermo Fisher Scientific Roche PacBio Perkinelmer Qiagen Agilent Technologies BGI Group By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
1 Study Coverage 1.1 Non-invasive Parenteral Screening Instruments Product Introduction 1.2 Market by Type 1.2.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Ultrasound Devices 1.2.3 Next-Generation Sequencing Systems 1.2.4 Polymerase Chain Reaction Instruments 1.2.5 Microarrays 1.2.6 Others 1.3 Market by Application 1.3.1 Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Diagnostic Laboratories 1.3.3 Hospitals 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Non-invasive Parenteral Screening Instruments Sales Estimates and Forecasts 2017-2028 2.2 Global Non-invasive Parenteral Screening Instruments Revenue Estimates and Forecasts 2017-2028 2.3 Global Non-invasive Parenteral Screening Instruments Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Non-invasive Parenteral Screening Instruments Sales by Region 2.4.1 Global Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) 2.4.2 Global Sales Non-invasive Parenteral Screening Instruments by Region (2023-2028) 2.5 Global Non-invasive Parenteral Screening Instruments Revenue by Region 2.5.1 Global Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) 2.5.2 Global Non-invasive Parenteral Screening Instruments Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers 3.1.1 Global Top Non-invasive Parenteral Screening Instruments Manufacturers by Sales (2017-2022) 3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-invasive Parenteral Screening Instruments in 2021 3.2 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers 3.2.1 Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022) 3.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Non-invasive Parenteral Screening Instruments Revenue in 2021 3.3 Global Non-invasive Parenteral Screening Instruments Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Non-invasive Parenteral Screening Instruments Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Non-invasive Parenteral Screening Instruments Sales by Type 4.1.1 Global Non-invasive Parenteral Screening Instruments Historical Sales by Type (2017-2022) 4.1.2 Global Non-invasive Parenteral Screening Instruments Forecasted Sales by Type (2023-2028) 4.1.3 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) 4.2 Global Non-invasive Parenteral Screening Instruments Revenue by Type 4.2.1 Global Non-invasive Parenteral Screening Instruments Historical Revenue by Type (2017-2022) 4.2.2 Global Non-invasive Parenteral Screening Instruments Forecasted Revenue by Type (2023-2028) 4.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) 4.3 Global Non-invasive Parenteral Screening Instruments Price by Type 4.3.1 Global Non-invasive Parenteral Screening Instruments Price by Type (2017-2022) 4.3.2 Global Non-invasive Parenteral Screening Instruments Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Non-invasive Parenteral Screening Instruments Sales by Application 5.1.1 Global Non-invasive Parenteral Screening Instruments Historical Sales by Application (2017-2022) 5.1.2 Global Non-invasive Parenteral Screening Instruments Forecasted Sales by Application (2023-2028) 5.1.3 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) 5.2 Global Non-invasive Parenteral Screening Instruments Revenue by Application 5.2.1 Global Non-invasive Parenteral Screening Instruments Historical Revenue by Application (2017-2022) 5.2.2 Global Non-invasive Parenteral Screening Instruments Forecasted Revenue by Application (2023-2028) 5.2.3 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) 5.3 Global Non-invasive Parenteral Screening Instruments Price by Application 5.3.1 Global Non-invasive Parenteral Screening Instruments Price by Application (2017-2022) 5.3.2 Global Non-invasive Parenteral Screening Instruments Price Forecast by Application (2023-2028) 6 North America 6.1 North America Non-invasive Parenteral Screening Instruments Market Size by Type 6.1.1 North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028) 6.1.2 North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028) 6.2 North America Non-invasive Parenteral Screening Instruments Market Size by Application 6.2.1 North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028) 6.2.2 North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028) 6.3 North America Non-invasive Parenteral Screening Instruments Market Size by Country 6.3.1 North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028) 6.3.2 North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Non-invasive Parenteral Screening Instruments Market Size by Type 7.1.1 Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028) 7.1.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028) 7.2 Europe Non-invasive Parenteral Screening Instruments Market Size by Application 7.2.1 Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028) 7.2.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028) 7.3 Europe Non-invasive Parenteral Screening Instruments Market Size by Country 7.3.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028) 7.3.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Type 8.1.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028) 8.1.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028) 8.2 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Application 8.2.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028) 8.2.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028) 8.3 Asia Pacific Non-invasive Parenteral Screening Instruments Market Size by Region 8.3.1 Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2017-2028) 8.3.2 Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Non-invasive Parenteral Screening Instruments Market Size by Type 9.1.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028) 9.1.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028) 9.2 Latin America Non-invasive Parenteral Screening Instruments Market Size by Application 9.2.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028) 9.2.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028) 9.3 Latin America Non-invasive Parenteral Screening Instruments Market Size by Country 9.3.1 Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028) 9.3.2 Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Type 10.1.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2028) 10.1.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2028) 10.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Application 10.2.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2028) 10.2.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2028) 10.3 Middle East and Africa Non-invasive Parenteral Screening Instruments Market Size by Country 10.3.1 Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2028) 10.3.2 Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 GE Healthcare 11.1.1 GE Healthcare Corporation Information 11.1.2 GE Healthcare Overview 11.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 GE Healthcare Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 GE Healthcare Recent Developments 11.2 Philips 11.2.1 Philips Corporation Information 11.2.2 Philips Overview 11.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Philips Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Philips Recent Developments 11.3 Illumina 11.3.1 Illumina Corporation Information 11.3.2 Illumina Overview 11.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Illumina Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Illumina Recent Developments 11.4 Thermo Fisher Scientific 11.4.1 Thermo Fisher Scientific Corporation Information 11.4.2 Thermo Fisher Scientific Overview 11.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Thermo Fisher Scientific Recent Developments 11.5 Roche 11.5.1 Roche Corporation Information 11.5.2 Roche Overview 11.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Roche Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Roche Recent Developments 11.6 PacBio 11.6.1 PacBio Corporation Information 11.6.2 PacBio Overview 11.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 PacBio Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 PacBio Recent Developments 11.7 Perkinelmer 11.7.1 Perkinelmer Corporation Information 11.7.2 Perkinelmer Overview 11.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Perkinelmer Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Perkinelmer Recent Developments 11.8 Qiagen 11.8.1 Qiagen Corporation Information 11.8.2 Qiagen Overview 11.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Qiagen Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Qiagen Recent Developments 11.9 Agilent Technologies 11.9.1 Agilent Technologies Corporation Information 11.9.2 Agilent Technologies Overview 11.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Agilent Technologies Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Agilent Technologies Recent Developments 11.10 BGI Group 11.10.1 BGI Group Corporation Information 11.10.2 BGI Group Overview 11.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 BGI Group Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 BGI Group Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Non-invasive Parenteral Screening Instruments Industry Chain Analysis 12.2 Non-invasive Parenteral Screening Instruments Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Non-invasive Parenteral Screening Instruments Production Mode & Process 12.4 Non-invasive Parenteral Screening Instruments Sales and Marketing 12.4.1 Non-invasive Parenteral Screening Instruments Sales Channels 12.4.2 Non-invasive Parenteral Screening Instruments Distributors 12.5 Non-invasive Parenteral Screening Instruments Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Non-invasive Parenteral Screening Instruments Industry Trends 13.2 Non-invasive Parenteral Screening Instruments Market Drivers 13.3 Non-invasive Parenteral Screening Instruments Market Challenges 13.4 Non-invasive Parenteral Screening Instruments Market Restraints 14 Key Findings in The Global Non-invasive Parenteral Screening Instruments Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Ultrasound Devices Table 3. Major Manufacturers of Next-Generation Sequencing Systems Table 4. Major Manufacturers of Polymerase Chain Reaction Instruments Table 5. Major Manufacturers of Microarrays Table 6. Major Manufacturers of Others Table 7. Global Non-invasive Parenteral Screening Instruments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Non-invasive Parenteral Screening Instruments Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (K Units) Table 10. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022) Table 11. Global Non-invasive Parenteral Screening Instruments Sales by Region (2023-2028) & (K Units) Table 12. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2023-2028) Table 13. Global Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million) Table 14. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region (2017-2022) Table 15. Global Non-invasive Parenteral Screening Instruments Revenue by Region (2023-2028) & (US$ Million) Table 16. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region (2023-2028) Table 17. Global Non-invasive Parenteral Screening Instruments Sales by Manufacturers (2017-2022) & (K Units) Table 18. Global Non-invasive Parenteral Screening Instruments Sales Share by Manufacturers (2017-2022) Table 19. Global Non-invasive Parenteral Screening Instruments Revenue by Manufacturers (2017-2022) & (US$ Million) Table 20. Global Non-invasive Parenteral Screening Instruments Revenue Share by Manufacturers (2017-2022) Table 21. Non-invasive Parenteral Screening Instruments Price by Manufacturers (2017-2022) &(USD/Unit) Table 22. Global Non-invasive Parenteral Screening Instruments Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Non-invasive Parenteral Screening Instruments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Parenteral Screening Instruments as of 2021) Table 24. Non-invasive Parenteral Screening Instruments Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Non-invasive Parenteral Screening Instruments Product Offered Table 26. Date of Manufacturers Enter into Non-invasive Parenteral Screening Instruments Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 29. Global Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 30. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2017-2022) Table 31. Global Non-invasive Parenteral Screening Instruments Sales Share by Type (2023-2028) Table 32. Global Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 33. Global Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 34. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2017-2022) Table 35. Global Non-invasive Parenteral Screening Instruments Revenue Share by Type (2023-2028) Table 36. Non-invasive Parenteral Screening Instruments Price by Type (2017-2022) & (USD/Unit) Table 37. Global Non-invasive Parenteral Screening Instruments Price Forecast by Type (2023-2028) & (USD/Unit) Table 38. Global Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 39. Global Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 40. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2017-2022) Table 41. Global Non-invasive Parenteral Screening Instruments Sales Share by Application (2023-2028) Table 42. Global Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 43. Global Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 44. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2017-2022) Table 45. Global Non-invasive Parenteral Screening Instruments Revenue Share by Application (2023-2028) Table 46. Non-invasive Parenteral Screening Instruments Price by Application (2017-2022) & (USD/Unit) Table 47. Global Non-invasive Parenteral Screening Instruments Price Forecast by Application (2023-2028) & (USD/Unit) Table 48. North America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 49. North America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 50. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 51. North America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 52. North America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 53. North America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 54. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 55. North America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 56. North America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (K Units) Table 57. North America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (K Units) Table 58. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million) Table 59. North America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million) Table 60. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 61. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 62. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 63. Europe Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 64. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 65. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 66. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 67. Europe Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 68. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (K Units) Table 69. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (K Units) Table 70. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million) Table 71. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million) Table 72. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 73. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 74. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 75. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 76. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 77. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 78. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 79. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 80. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2017-2022) & (K Units) Table 81. Asia Pacific Non-invasive Parenteral Screening Instruments Sales by Region (2023-2028) & (K Units) Table 82. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2017-2022) & (US$ Million) Table 83. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue by Region (2023-2028) & (US$ Million) Table 84. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 85. Latin America Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 86. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 87. Latin America Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 88. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 89. Latin America Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 90. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 91. Latin America Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 92. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (K Units) Table 93. Latin America Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (K Units) Table 94. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million) Table 95. Latin America Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million) Table 96. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2017-2022) & (K Units) Table 97. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Type (2023-2028) & (K Units) Table 98. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2017-2022) & (US$ Million) Table 99. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Type (2023-2028) & (US$ Million) Table 100. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2017-2022) & (K Units) Table 101. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Application (2023-2028) & (K Units) Table 102. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2017-2022) & (US$ Million) Table 103. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Application (2023-2028) & (US$ Million) Table 104. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2017-2022) & (K Units) Table 105. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales by Country (2023-2028) & (K Units) Table 106. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2017-2022) & (US$ Million) Table 107. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2023-2028) & (US$ Million) Table 108. GE Healthcare Corporation Information Table 109. GE Healthcare Description and Major Businesses Table 110. GE Healthcare Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 111. GE Healthcare Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 112. GE Healthcare Recent Developments Table 113. Philips Corporation Information Table 114. Philips Description and Major Businesses Table 115. Philips Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 116. Philips Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 117. Philips Recent Developments Table 118. Illumina Corporation Information Table 119. Illumina Description and Major Businesses Table 120. Illumina Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 121. Illumina Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 122. Illumina Recent Developments Table 123. Thermo Fisher Scientific Corporation Information Table 124. Thermo Fisher Scientific Description and Major Businesses Table 125. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 126. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 127. Thermo Fisher Scientific Recent Developments Table 128. Roche Corporation Information Table 129. Roche Description and Major Businesses Table 130. Roche Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 131. Roche Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 132. Roche Recent Developments Table 133. PacBio Corporation Information Table 134. PacBio Description and Major Businesses Table 135. PacBio Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 136. PacBio Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 137. PacBio Recent Developments Table 138. Perkinelmer Corporation Information Table 139. Perkinelmer Description and Major Businesses Table 140. Perkinelmer Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 141. Perkinelmer Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 142. Perkinelmer Recent Developments Table 143. Qiagen Corporation Information Table 144. Qiagen Description and Major Businesses Table 145. Qiagen Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 146. Qiagen Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 147. Qiagen Recent Developments Table 148. Agilent Technologies Corporation Information Table 149. Agilent Technologies Description and Major Businesses Table 150. Agilent Technologies Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 151. Agilent Technologies Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 152. Agilent Technologies Recent Developments Table 153. BGI Group Corporation Information Table 154. BGI Group Description and Major Businesses Table 155. BGI Group Non-invasive Parenteral Screening Instruments Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 156. BGI Group Non-invasive Parenteral Screening Instruments Product Model Numbers, Pictures, Descriptions and Specifications Table 157. BGI Group Recent Developments Table 158. Key Raw Materials Lists Table 159. Raw Materials Key Suppliers Lists Table 160. Non-invasive Parenteral Screening Instruments Distributors List Table 161. Non-invasive Parenteral Screening Instruments Customers List Table 162. Non-invasive Parenteral Screening Instruments Market Trends Table 163. Non-invasive Parenteral Screening Instruments Market Drivers Table 164. Non-invasive Parenteral Screening Instruments Market Challenges Table 165. Non-invasive Parenteral Screening Instruments Market Restraints Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Non-invasive Parenteral Screening Instruments Product Picture Figure 3. Global Non-invasive Parenteral Screening Instruments Market Share by Type in 2021 & 2028 Figure 3. Ultrasound Devices Product Picture Figure 4. Next-Generation Sequencing Systems Product Picture Figure 5. Polymerase Chain Reaction Instruments Product Picture Figure 6. Microarrays Product Picture Figure 7. Others Product Picture Figure 8. Global Non-invasive Parenteral Screening Instruments Market Share by Application in 2021 & 2028 Figure 9. Diagnostic Laboratories Figure 10. Hospitals Figure 11. Non-invasive Parenteral Screening Instruments Report Years Considered Figure 12. Global Non-invasive Parenteral Screening Instruments Sales 2017-2028 (K Units) Figure 13. Global Non-invasive Parenteral Screening Instruments Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Non-invasive Parenteral Screening Instruments Revenue 2017-2028 (US$ Million) Figure 15. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 16. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2017-2022) Figure 17. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2023-2028) Figure 18. North America Non-invasive Parenteral Screening Instruments Sales YoY (2017-2028) & (K Units) Figure 19. North America Non-invasive Parenteral Screening Instruments Revenue YoY (2017-2028) & (US$ Million) Figure 20. Europe Non-invasive Parenteral Screening Instruments Sales YoY (2017-2028) & (K Units) Figure 21. Europe Non-invasive Parenteral Screening Instruments Revenue YoY (2017-2028) & (US$ Million) Figure 22. Asia-Pacific Non-invasive Parenteral Screening Instruments Sales YoY (2017-2028) & (K Units) Figure 23. Asia-Pacific Non-invasive Parenteral Screening Instruments Revenue YoY (2017-2028) & (US$ Million) Figure 24. Latin America Non-invasive Parenteral Screening Instruments Sales YoY (2017-2028) & (K Units) Figure 25. Latin America Non-invasive Parenteral Screening Instruments Revenue YoY (2017-2028) & (US$ Million) Figure 26. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales YoY (2017-2028) & (K Units) Figure 27. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue YoY (2017-2028) & (US$ Million) Figure 28. The Non-invasive Parenteral Screening Instruments Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 29. The Top 5 and 10 Largest Manufacturers of Non-invasive Parenteral Screening Instruments in the World: Market Share by Non-invasive Parenteral Screening Instruments Revenue in 2021 Figure 30. Global Non-invasive Parenteral Screening Instruments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 31. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 32. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 33. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 34. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 35. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 36. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 37. North America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 38. North America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 39. North America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028) Figure 40. North America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028) Figure 41. U.S. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 42. Canada Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 43. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 44. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 45. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 46. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 47. Europe Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028) Figure 48. Europe Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028) Figure 49. Germany Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 50. France Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 51. U.K. Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 52. Italy Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 53. Russia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 54. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 55. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 56. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 57. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 58. Asia Pacific Non-invasive Parenteral Screening Instruments Sales Share by Region (2017-2028) Figure 59. Asia Pacific Non-invasive Parenteral Screening Instruments Revenue Share by Region (2017-2028) Figure 60. China Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 61. Japan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 62. South Korea Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 63. India Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 64. Australia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 65. Taiwan Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 66. Indonesia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 67. Thailand Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 68. Malaysia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 69. Philippines Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 70. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 71. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 72. Latin America Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 73. Latin America Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 74. Latin America Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028) Figure 75. Latin America Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028) Figure 76. Mexico Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 77. Brazil Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 78. Argentina Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 79. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2017-2028) Figure 80. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2017-2028) Figure 81. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2017-2028) Figure 82. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2017-2028) Figure 83. Middle East and Africa Non-invasive Parenteral Screening Instruments Sales Share by Country (2017-2028) Figure 84. Middle East and Africa Non-invasive Parenteral Screening Instruments Revenue Share by Country (2017-2028) Figure 85. Turkey Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 86. Saudi Arabia Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 87. U.A.E Non-invasive Parenteral Screening Instruments Revenue (2017-2028) & (US$ Million) Figure 88. Non-invasive Parenteral Screening Instruments Value Chain Figure 89. Non-invasive Parenteral Screening Instruments Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed